Navigation Links
EnteroMedics Reports Second Quarter 2014 Financial Results
Date:8/7/2014

to investigational use.

The implantation procedure and usage of the Maestro® System carry some risks, such as the risks generally associated with laparoscopic procedures and those related to treatment as described in the ReCharge clinical trial informed consent.

(See attached tables)

 

 ENTEROMEDICS INC.Condensed Consolidated Statements of Operations (unaudited)(in thousands, except per share data)Three Months EndedSix Months EndedJune 30,June 30,2014201320142013Sales$

$

$

$

Cost of goods soldGross profitOperating expenses:Research and development3,0882,7125,7115,445Selling, general and administrative4,2663,3598,2016,945Total operating expenses7,3546,07113,91212,390Operating loss(7,354)

SOURCE EnteroMedics Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. EnteroMedics to Participate in Canaccord Genuity 34th Annual Growth Conference
2. EnteroMedics to Host Second Quarter 2014 Financial Results and Business Update Conference Call
3. Vanda Pharmaceuticals Reports Second Quarter 2014 Results
4. Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2014 Second Quarter Financial Results
5. PTC Therapeutics Reports Second Quarter Financial Results and Provides Corporate Update
6. Mylan Reports Second Quarter 2014 Adjusted Diluted EPS of $0.69, In Line With Guidance
7. Hill-Rom Reports Improved Fiscal Third Quarter Results; Updates Full-Year Guidance
8. Regulus Reports Second Quarter 2014 Financial Results and Recent Highlights
9. Depomed Reports Second Quarter 2014 Financial Results
10. BioScrip Reports Second Quarter 2014 Financial Results
11. Delcath Reports 2014 Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... LONDON , September 4, 2015 ... & Vaccines  Allergic Rhinitis drugs ... revenues Where is the market for allergic ... this market? Visiongain ,s new report shows you ... opportunities and prospects. Our 326 page report ...
(Date:9/4/2015)... Sep. 04, 2015 ... the addition of the "Veterinary Pharmaceutical Submissions ... 2015)" conference to their offering. ... all of the constituent parts of the application ... for which a marketing authorisation is sought in ...
(Date:9/4/2015)... , Sep. 04, 2015 ... http://www.researchandmarkets.com/research/dvzsqg/investigation ) has announced the addition of ... Hyaluronate Market, 2010-2019" report to their ... long-chain polymer containing repeating disaccharide units of ... fluid and cartilage matrix, sodium hyaluronate can ...
Breaking Medicine Technology:Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7Veterinary Pharmaceutical Submissions in the EU: Two day Course - London, UK - December 7-8, 2015 2Investigation Report on China's Sodium Hyaluronate Market 2015 2
... Feb. 16, 2011 Fujitsu , ... it will showcase its network scanning solutions for improved ... patients at the Annual HIMSS Conference & Exhibition (Booth ... adoption of network scanners has gained tremendous momentum by ...
... Sanofi-aventis (EURONEXT: SAN and NYSE: SNY ) and ... they have entered into a definitive agreement under which sanofi-aventis ... or approximately $20.1 billion(1). In addition to the cash payment, ... for each share they own, entitling the holder to receive ...
Cached Medicine Technology:Fujitsu to Showcase New Document Imaging Technologies for Improved Information Sharing and Record Keeping at HIMSS 2011 2Fujitsu to Showcase New Document Imaging Technologies for Improved Information Sharing and Record Keeping at HIMSS 2011 3Sanofi-aventis to Acquire Genzyme for $74.00 in Cash Per Share Plus Contingent Value Right 2Sanofi-aventis to Acquire Genzyme for $74.00 in Cash Per Share Plus Contingent Value Right 3Sanofi-aventis to Acquire Genzyme for $74.00 in Cash Per Share Plus Contingent Value Right 4Sanofi-aventis to Acquire Genzyme for $74.00 in Cash Per Share Plus Contingent Value Right 5Sanofi-aventis to Acquire Genzyme for $74.00 in Cash Per Share Plus Contingent Value Right 6Sanofi-aventis to Acquire Genzyme for $74.00 in Cash Per Share Plus Contingent Value Right 7Sanofi-aventis to Acquire Genzyme for $74.00 in Cash Per Share Plus Contingent Value Right 8
(Date:9/4/2015)... CA (PRWEB) , ... September 04, 2015 , ... ... announces that CEREC technology is now available at CitiDent. CEREC is a newer ... In addition to saving time for patients by eliminating the need for multiple ...
(Date:9/4/2015)... ... September 04, 2015 , ... The USC Eye Institute is proud to announce ... Doximity. Faculty, residents and staff are honored to have contributed to the success ... our ophthalmology residency program. Our faculty places a high priority on our educational programs ...
(Date:9/4/2015)... ... 2015 , ... Steven Winter Associates, Inc., (SWA) is pleased ... for the Residential Award of Merit by the Connecticut Green Building Council (CTGBC) ... highly competitive field of submissions, the net-zero energy residence will be honored at ...
(Date:9/4/2015)... ... September 04, 2015 , ... Friday night, Chicago lovebirds Jenny McCarthy and ... Night of Hope event supporting families affected by autism, raising nearly $250,000. , ... joined together at the Oscar Swan Inn to support the cause. , McCarthy ...
(Date:9/3/2015)... IL (PRWEB) , ... September 03, 2015 , ... ... Diagnostics Inc. , a privately held medical technology company that will bring low-cost ... select markets worldwide. , Preora’s proprietary and automated technology platform detects and ...
Breaking Medicine News(10 mins):Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 3Health News:South Glastonbury Home Selected for Award by Connecticut Green Building Council 2Health News:Jenny McCarthy & Donnie Wahlberg Help Raise Over $200,000 For Generation Rescue’s ‘Night Of Hope’ Chicago Charity Event 2Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 2Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 3
... Parallel caret ,R, Software Provides Faster Analysis of Safety ... ... IT World Conference and Exposition,-- REvolution Computing, the leading provider ... results of "A,Benchmark Study of Large-Scale Chemical Classification on Quad-Core ...
... the wrong time, CDC study finds , , TUESDAY, April 29 ... quarter of American toddlers may be under-vaccinated. , The study ... missed doses account for about two-thirds of non-compliance to official ... a study conducted by the U.S. Centers for Disease Control ...
... Webcast:, What: HCA Webcast, When: ... http://www.videonewswire.com/event.asp?id=47214 , How: ... at the ... live webcast, the call will,be archived on the Web site http://www.hcahealthcare.com ...
... Former employee brings design and management expertise to ... Product Development is,pleased to announce the appointment of ... engineering. Havard brings more than 21 years experience,to ... Stratos, staff is internationally recognized as some of ...
... Joins Digirad Centers of Influence To Deliver ... Advanced ... DRAD ), a leading provider of medical diagnostic imaging ... the signing of a letter of agreement with the University ...
... 29, 2008 Foodborne diseases cause an estimated 76 ... half associated with restaurant meals. More than 70 billion ... U.S., accounting for 47% of total food expenditure. Therefore, ... public health departments. According to an article published in ...
Cached Medicine News:Health News:Pfizer Partners with REvolution Computing to Improve Medicine Production Pipeline 2Health News:Pfizer Partners with REvolution Computing to Improve Medicine Production Pipeline 3Health News:1 in 4 U.S. Toddlers Improperly Vaccinated 2Health News:1 in 4 U.S. Toddlers Improperly Vaccinated 3Health News:Stratos Product Development Welcomes Back John Havard as Vice President of Engineering 2Health News:Digirad Corporation and University of Chicago Medical Center Sign Letter of Agreement 2Health News:Digirad Corporation and University of Chicago Medical Center Sign Letter of Agreement 3Health News:Digirad Corporation and University of Chicago Medical Center Sign Letter of Agreement 4Health News:Restaurant inspections -- public perceptions vs. reality 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: